Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Takeda unblinds ELM-PC 5 phase III study of orteronel in patients with mCRPC
Takeda unblinds ELM-PC 5 phase III study of orteronel in patients with mCRPC
Takeda unblinds ELM-PC 5 phase III study of orteronel in patients with mCRPC
Submitted by
admin
on July 27, 2013 - 11:45am
Source:
Pharmabiz
News Tags:
Takeda
ELM-PC
prostate cancer
Headline:
Takeda unblinds ELM-PC 5 phase III study of orteronel in patients with mCRPC
Do Not Allow Advertisers to Use My Personal information
